In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  aminolevulinic acid hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PDT for Lip, NCT00868088

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: NPC-07-1, NCT01167322

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-1050, 1R21CA156227-01A1, NCT01525329

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALA-AK-CT007, 2013-002510-12, NCT01966120

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 51439, NCT00571974

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DS 92-42, RPCI-DS-92-42, NCI-V97-1191, NCT00002963

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000065494, RPCI-DS-96-55, NCI-G97-1224, NCT00002975

8.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: DS 97-32, RPCI-DS-9732, NCT00054171

9.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DUSA-PDT-BCC-06, DUSA-PDT-BCC-06, NCT00747903

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696316, CRUK-UCL-09-0398, 2010-022496-66, 09/0398, 10/H0304/100, UCL/09/0398 v2.0, GALA-5, EUDRACT-2010-022496-66, NCT01310868

11.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 5-ALA-01, NCT01403311

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP0106, NCT01458587

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP0105, NCT01475955

14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2011-077, ML28244, NCT01556009

15.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: 4079, NCT00671710

16.

Phase: Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DMS 0711, R01 NS052274-01A2, NCT00870779

17.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE-9Z07-CC417, P30CA043703, P01CA084203, NCT00663910

18.

Phase: No phase specified
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: INV-0901, NCT01053000

19.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NIS 01, NCT01571336

20.

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 282150, NCT01812837
New Search